Bernard L. Schwartz Distinguished Professorship in Urologic Oncology

School of Medicine

Established in 1996 by Bernard L. and Irene Schwartz

BERNARD LEON SCHWARTZ is chairman and CEO of BLS Investments, LLC, a private investment firm. He also manages the investments of the Bernard and Irene Schwartz Foundation, which mainly supports higher education, medical research, and New York City-based cultural organizations. He promotes the development of U.S. economic policy initiatives through investment in educational institutions, think tanks, and advocacy organizations. Prior to establishing BLS Investments in March 2006, Mr. Schwartz served for 34 years as chairman of the board and chief executive officer of Loral Space & Communications and its predecessor company, Loral Corporation.

He has also been active in civic and political affairs. Mr. Schwartz serves as a trustee of the New York University Hospitals Center, the New York Historical Society, Thirteen/WNET Educational Broadcasting Corporation, and Baruch College. He is also vice president of the New York Film Society.

In addition, Mr. Schwartz is a director of the New America Foundation, where he supports its fellowship program; chairman of the board of trustees of Third Way, a progressive advocacy organization; and a supporter of the Democratic Leadership Council.

He has received many honors, including the 1995 Man of the Year award of the Weitzmann Institute of Science, the Townsend Harris Medal for civic achievement, and the Eisenhower Award from Business Executives for National Defense. A longtime friend of Hopkins, Mr. Schwartz has served on the Nitze School of Advanced International Studies Board of Advisors. He provided for the Bernard L. Schwartz Distinguished Professorship in Urologic Oncology and the Bernard L. Schwartz Professorship in Political Economy. He was presented with the Founder’s Award at SAIS in 2009.

Held by Christian P. Pavlovich

CHRISTIAN P. PAVLOVICH, M.D., is Professor of Urology at the Johns Hopkins University School of Medicine. He is the Director of the Prostate Cancer Active Surveillance Program and Fellowship Director of Urologic Oncology for the Brady Urological Institute.

Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life, while offering patients the latest treatment options and techniques.

His clinical focus is on prostate cancer, kidney cancer, and associated disorders, and on clinical trials regarding cancer detection and cancer immunotherapy. He is experienced in performing open, laparoscopic and other minimally invasive surgeries for the management of urologic tumors, including nerve-sparing and robot-assisted laparoscopic radical prostatectomy, laparoscopic and robotic nephrectomy, nephroureterectomy, and partial nephrectomy, and robotic radical cystectomy. In addition, he offers patients active surveillance and ablative options for their urinary malignancies including cryotherapy and prostate laser ablation.

He has been a National Institutes of Health- and Department of Defense-funded investigator whose research focuses on identifying early-detection methods for prostate and kidney cancer, including novel urinary biomarkers and imaging modalities for these diseases.

Dr. Pavlovich earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He completed a urology residency at New York Hospital and a National Cancer Institute fellowship in urologic oncology before joining the Hopkins faculty in 2001.

American Board of Urology-certified, Dr. Pavlovich has published over 100 peer-reviewed articles and is on the Editorial Board of the British Journal of Urology International.

Dr. Pavlovich speaks English, French, Spanish, German, Croatian and Serbian.